September 24, 2019
With more than three decades of healthcare experience, most recently as CEO of St. Christopher’s Hospital for Children, Maria Scenna steps into leadership position with national oncology network.
Read MoreSeptember 24, 2019
With more than three decades of healthcare experience, most recently as CEO of St. Christopher’s Hospital for Children, Maria Scenna steps into leadership position with national oncology network.
Read MoreSeptember 19, 2019
Independence Blue Cross (Independence), the leading health insurer in southeastern Pennsylvania, and Cancer Treatment Centers of America (CTCA) Philadelphia, part of a national network of cancer care providers, have signed a new four-year agreement....
Read MoreJuly 30, 2019
Cancer Treatment Centers of America® (CTCA) Chicago has been named a High Performing Hospital in Lung Cancer Surgery by U.S. News & World Report.
Read MoreJune 25, 2019
Cancer Treatment Centers of America® (CTCA), Chicago, has honored CTCA® Chicago nurse, Mike Stimac, RN with the DAISY Award for Extraordinary Nurses in recognition for his commitment and patient-centered approach to care. The award is part of the...
Read MoreJune 24, 2019
Cancer Treatment Centers of America® (CTCA), Chicago has named Adrienne Schultz, MSN, RN, HN-BC, vice president of patient care services and chief nursing officer. Schultz previously served as assistant vice president of patient care services at...
Read MoreJune 17, 2019
In March, the National Comprehensive Cancer Network (NCCN) released updated guidelines stating that Heated Intraperitoneal Chemotherapy (HIPEC) using the chemotherapy drug cisplatin can be considered with debulking surgery for stage III epithelial...
Read MoreJune 14, 2019
Read More
April 23, 2019
Cancer Treatment Centers of America® (CTCA) Chicago has honored CTCA® Chicago nurse, Julie Rout, RN BSN OCN, with the DAISY Award for Extraordinary Nurses in recognition for her commitment and patient-centered approach to care.
Read MoreApril 23, 2019
Physicians at Cancer Treatment Centers of America® (CTCA) Chicago have a new option in the fight against rare neuroendocrine tumors (NETs) with the introduction of an innovative therapy called lutetium Lu 177 dotatate (Lutathera®).
Read MoreApril 03, 2019
Pat A. Basu, MD, MBA, an accomplished health care executive and entrepreneur, has been appointed President and Chief Executive Officer of Cancer Treatment Centers of America Global, Inc., which includes the existing Comprehensive Cancer Care Network...
Read More